Acute chest syndrome in sickle cell disease and acute respiratory distress syndrome - From pathophysiology to therapy;Drépanocytose: Syndromes thoracique aigu et de détresse respiratoire. De la pathophysiologie au traitement

Revue Medicale Suisse

Volumn 2, Issue 91, 2006, Pages 2852-2857

  Charbonney, Emmanuel ^a   Terrettaz, Marianne ^a   Vuilleumier, Nicolas ^c   Lambert, Jean François ^b  

^a SERVICE DE MÉDECINE INTERNE GÉNÉRALE   (Switzerland)

^b Division d'Hématologie   (Switzerland)

^c Lab Central de Chimie Clinique   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; NITRIC OXIDE;

ACUTE CHEST SYNDROME; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD OXYGENATION; BLOOD TRANSFUSION; CELL ADHESION; CHELATION THERAPY; DISEASE EXACERBATION; ERYTHROCYTE; FEVER; GENE MUTATION; HUMAN; LUNG INFILTRATE; PNEUMONIA; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA; THORAX RADIOGRAPHY;

ACUTE DISEASE; ADULT; ANEMIA, SICKLE CELL; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 33846422006     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: Pathogenesis and rationale for treatment. Blood 1999;94:1555-60.
2. Gladwin MT, Schlechter AN, Shelhamer JH, Ognibene FP. The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment. Am J Respir Crit Care Med 1999; 159:1368-76.
3. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364:1343-60.
4. Aliyu ZY, Tumblin AR, Kato GJ. Current therapy of sickle cell disease. Haematologica 2006;91:7-10.
5. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342:1855-65.
6. Minter KR, Gladwin MT. Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research. Am J Respir Crit Care Med 2001;164:2016-9.
7. Vichinsky E, Williams R, Das M, et al. Pulmonary fat embolism: A distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994;83:3107-12.
8. Godeau B, Schaeffer A, Bachir D, et al. Broncho-alveolar lavage in adult sickle cell patients with acute chest syndrome: Value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med 1996;153:1691-6.
9. Kuypers FA, Styles LA. The role of secretory phospholipase A2 in acute chest syndrome. Cell Mol Biol (Noisy-le-grand) 2004;50:87-94.
10. Blum A, Yeganeh S, Peleg A, et al. Endothelial function in patients with sickle cell anemia during and after sickle cell crises. J Thromb Thrombolysis 2005;19:83-6.
11. Hebbel RP, Visser MR, Goodman JL, Jacob HS, Vercellotti GM. Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest 1987;80:1503-6.
12. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
13. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
14. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002;8:1383-9. Epub 2002 Nov 11.
15. Gladwin MT, Kato GJ. Cardiopulmonary complications of sickle cell disease: Role of nitric oxide and hemolytic anemia. Hematology (Am Soc Hematol Educ Program) 2005:51-7.
16. Kato GJ, Hsieh M, Machado R, et al. Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol 2006;81:503-10.
17. Ortiz FO, Aldrich TK, Nagel RL, Benjamin LJ. Accuracy of pulse oximetry in sickle cell disease. Am J Respir Crit Care Med 1999;159:447-51.
18. Knight-Madden JA, Hambleton IR. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev 2003: CD003733.
19. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91:288-94.
20. Melton CW, Haynes J, Jr. Sickle acute lung injury: Role of prevention and early aggressive intervention strategies on outcome. Clin Chest Med 2006;27:487-502, vii.
21. Wanko SO, Telen MJ. Transfusion management in sickle cell disease. Hematol Oncol Clin North Am 2005;19:803-26, v-vi.
22. Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 1995;333:699-703.
23. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.
24. Taylor C, Carter F, Poulose J, et al. Clinical presentation of acute chest syndrome in sickle cell disease. Postgrad Med J 2004;80:346-9.
25. Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C. Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 1999;25:911-9.
26. Hrinczenko BW, Alayash AI, Wink DA, et al. Effect of nitric oxide and nitric oxide donors on red blood cell oxygen transport. Br J Haematol 2000;110:412-9.
27. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60-8.
28. Bernini JC, Rogers ZR, Sandler ES, et al. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998;92:3082-9.
29. Suter PM. Lung Inflammation in ARDS-friend or foe? N Engl J Med 2006;354:1739-42.
30. Gladwin MT, Shelhamer JH, Ognibene FP, et al. Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol 2002;116:436-44.